Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.75 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.62 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.54 |
| ▸ | PAM | P19021 | 2/20 | 0.53 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.53 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.53 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.53 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.53 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.53 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6861802 | 0.95 | DGKA (0.68) | DGKAFFAR4FFAR1LMNAKDM4E | |
| SCHEMBL3487129 | 0.95 | DGKA (0.67) | DGKAFFAR4FFAR1LMNAKDM4E | |
| SCHEMBL3487063 | 0.95 | DGKA (0.67) | DGKAFFAR4FFAR1LMNAKDM4E | |
| SCHEMBL8329472 | 0.95 | DGKA (0.67) | DGKAFFAR4FFAR1LMNAKDM4E | |
| SCHEMBL21585872 | 0.95 | DGKA (0.67) | DGKAFFAR4FFAR1LMNAKDM4E | |
| SCHEMBL3487884 | 0.95 | DGKA (0.67) | DGKAFFAR4FFAR1LMNAKDM4E | |
| SCHEMBL294266 | 0.95 | DGKA (0.67) | DGKAFFAR4FFAR1LMNAKDM4E | |
| SCHEMBL1683778 | 0.95 | DGKA (0.67) | DGKAFFAR4FFAR1LMNAKDM4E | |
| SCHEMBL21585874 | 0.95 | DGKA (0.67) | DGKAFFAR4FFAR1LMNAKDM4E | |
| SCHEMBL1683831 | 0.95 | DGKA (0.67) | DGKAFFAR4FFAR1LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 359 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586658-B2 | Polylactic acid resin composition and molded item | NEC CORPORATION (JP) | 2013-11-19 | — | — | US | claimed |
| EP-1276455-B1 | ANHYDROUS ANTIPERSPIRANT COMPOSITION CONTAINING POLYSACCHARIDES | HENKEL AG & CO KGAA (DE) | 2008-12-24 | — | — | EP | claimed |
| EP-4727514-A1 | DEODORANT COMPOSITIONS COMPRISING CARBOXYLIC ACIDS | The Procter & Gamble Company (US) | 2026-04-22 | — | — | EP | disclosed |
| WO-2025261968-A1 | ALKYLESTER OF ANDIROBA OIL | BASF SE (DE) | 2025-12-26 | — | — | WO | disclosed |
| EP-4366690-B1 | POLYOL ESTER MIXTURE FOR USE AS VASELINE SUBSTITUTE | BASF SE (DE) | 2025-06-25 | — | — | EP | disclosed |
| EP-4531797-A2 | DEODORANT COMPOSITIONS COMPRISING LIPOPHILIC CARBOXYLIC ACIDS | The Procter & Gamble Company (US) | 2025-04-09 | — | — | EP | disclosed |
| EP-3562558-B1 | ANHYDROUS COMPOSITION COMPRISING A MAGNESIUM SALT | OREAL (FR) | 2025-03-12 | — | — | EP | disclosed |
| US-20250045844-A1 | ENVIRONMENTAL ATTRIBUTES FOR COSMETIC INGREDIENTS | BASF SE (DE) | 2025-02-06 | — | — | US | disclosed |
| US-20240415753-A1 | DEODORANT COMPOSITIONS COMPRISING CARBOXYLIC ACIDS | THE PROCTER & GAMBLE COMPANY | 2024-12-19 | — | — | US | disclosed |
| WO-2024259180-A1 | DEODORANT COMPOSITIONS COMPRISING CARBOXYLIC ACIDS | THE PROCTER & GAMBLE COMPANY (US) | 2024-12-19 | — | — | WO | disclosed |
| EP-4453822-A1 | ENVIRONMENTAL ATTRIBUTES FOR COSMETIC INGREDIENTS | BASF SE (DE) | 2024-10-30 | — | — | EP | disclosed |
| WO-1998027949-A1 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027951-A2 | ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS SUBSTANTIALLY FREE OF SELECT POLAR SOLVENTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027952-A1 | METHODS OF MAKING LOW RESIDUE ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027953-A1 | LOW RESIDUE ANTIPERSPIRANT GEL-SOLID STICK COMPOSITIONS CONTAINING SELECT GELLANTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| US-5750096-A | SOLID NON-POLYMERIC GELLANT BASED ON 12-HYDROXYSTEARIC ACID; ANHYDROUS LIQUID CARRIER | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-12 | — | — | US | disclosed |
| US-5744130-A | COMPRISING ACTIVE MATERIAL, NONPOLYMERIC GELLANT, ANHYDROUS LIQUID CARRIER; LOW RESIDUE | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-28 | — | — | US | disclosed |
| WO-1998016196-A1 | COMPOSITIONS AND METHODS FOR IMPROVING THE PERFORMANCE OF LONG-WEARING COSMETIC PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-23 | — | — | WO | disclosed |
| WO-1997017942-A1 | ANTIPERSPIRANT CREAM COMPOSITIONS HAVING IMPROVED RHEOLOGY | THE PROCTER & GAMBLE COMPANY (US) | 1997-05-22 | — | — | WO | disclosed |
| US-5387658-A | Oil thickeners; colorless, aging resistance; reaction product of castor oil, esters of ricinoleic or 12-hydroxystearic acid and epoxides | HUELS AKTIENGESELLSCHAFT (DE) | 1995-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240415753-A1 | DEODORANT COMPOSITIONS COMPRISING CARBOXYLIC ACIDS | ALOX5, DRD5, LBR | DGKA 84/4885FFAR4 27/4885FFAR1 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.